Jiao, De <br/><br/>
Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway.  [electronic resource] 

 -  Oncology reports  Jul 2016 
 - 342-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2016.4777  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Breast Neoplasms--drug therapy<br/>Caspase 3--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cyclin D1--metabolism<br/>Female<br/>Flavonoids--pharmacology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Glycogen Synthase Kinase 3--metabolism<br/>Humans<br/>Inhibitor of Apoptosis Proteins--metabolism<br/>MAP Kinase Signaling System--drug effects<br/>MCF-7 Cells<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Signal Transduction--drug effects<br/>Survivin<br/>bcl-2-Associated X Protein--metabolism<br/>beta Catenin--metabolism<br/>p21-Activated Kinases--metabolism